Cognitive impairment in men with testicular cancer prior to adjuvant therapy

Abstract

The prevalence of cognitive impairment in men with newly diagnosed NSGCT is unexpectedly high before the receipt of adjuvant chemotherapy. Efforts to track cognitive function over time and to develop effective interventions are warranted.